CN103562208B - 三环促旋酶抑制剂 - Google Patents
三环促旋酶抑制剂 Download PDFInfo
- Publication number
- CN103562208B CN103562208B CN201280020849.4A CN201280020849A CN103562208B CN 103562208 B CN103562208 B CN 103562208B CN 201280020849 A CN201280020849 A CN 201280020849A CN 103562208 B CN103562208 B CN 103562208B
- Authority
- CN
- China
- Prior art keywords
- compound
- mmol
- group
- mixture
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C*C1C(C)NC(N(C)C)=NC1 Chemical compound C*C1C(C)NC(N(C)C)=NC1 0.000 description 18
- WUFQLZTXIWKION-UHFFFAOYSA-N C(C1)CN(C2)C1=Nc1c2cccc1 Chemical compound C(C1)CN(C2)C1=Nc1c2cccc1 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 description 2
- HNASHRGEVPFYRP-UHFFFAOYSA-N CC(B1)C1NC1C2(CC2)CNC1 Chemical compound CC(B1)C1NC1C2(CC2)CNC1 HNASHRGEVPFYRP-UHFFFAOYSA-N 0.000 description 1
- QDZCHLGWKVLZTE-UHFFFAOYSA-N CC1=CC(c2n[nH][n-][nH+]2)=CNC1 Chemical compound CC1=CC(c2n[nH][n-][nH+]2)=CNC1 QDZCHLGWKVLZTE-UHFFFAOYSA-N 0.000 description 1
- PFKIMXXAICJSON-UHFFFAOYSA-N CCCOCCNC(CC(NC1)=NCC1C(C)C)=O Chemical compound CCCOCCNC(CC(NC1)=NCC1C(C)C)=O PFKIMXXAICJSON-UHFFFAOYSA-N 0.000 description 1
- VRKWNSJOKQVIKA-UHFFFAOYSA-N CCOC(c(c1cc(F)c2)c(NC(NC(C)=O)=S)[nH]c1c2N(C)C(OC(C)(C)C)=O)=O Chemical compound CCOC(c(c1cc(F)c2)c(NC(NC(C)=O)=S)[nH]c1c2N(C)C(OC(C)(C)C)=O)=O VRKWNSJOKQVIKA-UHFFFAOYSA-N 0.000 description 1
- ZHVAMJZPJZRZGG-OADYLZGLSA-N C[C@@H](C(C1CC1)=O)N(C(c1c2cccc1)O)C2=O Chemical compound C[C@@H](C(C1CC1)=O)N(C(c1c2cccc1)O)C2=O ZHVAMJZPJZRZGG-OADYLZGLSA-N 0.000 description 1
- XERSTAKQEMCKDZ-UHFFFAOYSA-N C[N]1(C)nnnc1-c1cncc(OCc2ccccc2)c1 Chemical compound C[N]1(C)nnnc1-c1cncc(OCc2ccccc2)c1 XERSTAKQEMCKDZ-UHFFFAOYSA-N 0.000 description 1
- FIKPRWPZTVPQJC-UHFFFAOYSA-N C[n]1nnnc1-c1cncc(O)c1 Chemical compound C[n]1nnnc1-c1cncc(O)c1 FIKPRWPZTVPQJC-UHFFFAOYSA-N 0.000 description 1
- IJBONYUNKRDIFC-UHFFFAOYSA-N Cc1ncc(C=O)cn1 Chemical compound Cc1ncc(C=O)cn1 IJBONYUNKRDIFC-UHFFFAOYSA-N 0.000 description 1
- NVYMOVCPYONOSF-UHFFFAOYSA-N Nc(nc1)ncc1O Chemical compound Nc(nc1)ncc1O NVYMOVCPYONOSF-UHFFFAOYSA-N 0.000 description 1
- VIZYFHZVBGCOAH-UHFFFAOYSA-N Oc1cnc(cccn2)c2c1 Chemical compound Oc1cnc(cccn2)c2c1 VIZYFHZVBGCOAH-UHFFFAOYSA-N 0.000 description 1
- OQKBLBZCSUDXFC-UHFFFAOYSA-O [NH3+]C(C1)C2C1CNC2 Chemical compound [NH3+]C(C1)C2C1CNC2 OQKBLBZCSUDXFC-UHFFFAOYSA-O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161453011P | 2011-03-15 | 2011-03-15 | |
| US61/453,011 | 2011-03-15 | ||
| PCT/US2012/029104 WO2012125746A1 (en) | 2011-03-15 | 2012-03-14 | Tricyclic gyrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103562208A CN103562208A (zh) | 2014-02-05 |
| CN103562208B true CN103562208B (zh) | 2016-08-31 |
Family
ID=45879060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280020849.4A Active CN103562208B (zh) | 2011-03-15 | 2012-03-14 | 三环促旋酶抑制剂 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9732083B2 (https=) |
| EP (1) | EP2686320B1 (https=) |
| JP (1) | JP6140083B2 (https=) |
| KR (2) | KR20140059164A (https=) |
| CN (1) | CN103562208B (https=) |
| AR (1) | AR085806A1 (https=) |
| AU (1) | AU2012229997B2 (https=) |
| BR (1) | BR112013023266B8 (https=) |
| CA (1) | CA2829939C (https=) |
| IL (1) | IL228220A (https=) |
| MX (1) | MX345780B (https=) |
| PH (1) | PH12013501800A1 (https=) |
| RU (1) | RU2626979C2 (https=) |
| TW (1) | TWI527818B (https=) |
| WO (1) | WO2012125746A1 (https=) |
| ZA (1) | ZA201307583B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2686320B1 (en) * | 2011-03-15 | 2016-05-18 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| EP2807165B1 (en) * | 2012-01-27 | 2019-05-15 | Université de Montréal | Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells |
| CN105189505B (zh) * | 2012-09-12 | 2019-03-22 | 默克夏普&多梅有限公司 | 用作抗菌剂的三环促旋酶抑制剂 |
| CN103304488B (zh) * | 2013-06-13 | 2015-12-09 | 暨明医药科技（苏州）有限公司 | 光学纯2-（1-羟基乙基）-5-羟基嘧啶的制备方法 |
| CN105899511B (zh) * | 2013-09-11 | 2019-06-07 | 默沙东公司 | 三环促旋酶抑制剂 |
| US20170007615A1 (en) | 2014-02-03 | 2017-01-12 | Biota Europe Ltd | Antibacterial Compounds |
| WO2015150337A1 (en) * | 2014-04-01 | 2015-10-08 | Amakem Nv | Lim kinase inhibitors |
| CA3057431A1 (en) | 2017-03-24 | 2018-09-27 | Taisho Pharmaceutical Co., Ltd. | 2(1h)-quinolinone derivative |
| CN110475777B (zh) * | 2017-03-30 | 2022-04-15 | 豪夫迈·罗氏有限公司 | 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物 |
| CN108504647B (zh) * | 2018-03-09 | 2021-11-05 | 中山大学 | 一种dna促旋酶的药物结合口袋及其应用 |
| JP7296992B2 (ja) * | 2018-05-28 | 2023-06-23 | エフ． ホフマン－ラ ロシュ アーゲー | 細菌感染症の処置および予防のための新規オキソキノリジン化合物 |
| WO2020064661A1 (en) * | 2018-09-26 | 2020-04-02 | F. Hoffmann-La Roche Ag | Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection |
| EP3887370B1 (en) * | 2018-11-27 | 2023-01-18 | F. Hoffmann-La Roche AG | Tricyclic compounds for the treatment and prophylaxis of bacterial infection |
| WO2020109191A1 (en) | 2018-11-27 | 2020-06-04 | F. Hoffmann-La Roche Ag | Aryl compounds for the treatment and prophylaxis of bacterial infection |
| WO2020127624A1 (en) | 2018-12-20 | 2020-06-25 | F. Hoffmann-La Roche Ag | Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infection |
| CN114763357B (zh) * | 2021-01-15 | 2024-06-18 | 中国科学院上海药物研究所 | 吲哚并嘧啶三环类化合物及其制备方法和用途 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003062443A2 (en) * | 2001-11-08 | 2003-07-31 | Antex Pharma, Inc. | Novel substituted alkane compounds and uses thereof |
| US20050227992A1 (en) * | 2003-10-14 | 2005-10-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein kinase inhibitors |
| CN101282946A (zh) * | 2005-08-05 | 2008-10-08 | 海布里詹尼克斯股份公司 | 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 |
| WO2009029473A1 (en) * | 2007-08-27 | 2009-03-05 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| WO2010006032A1 (en) * | 2008-07-10 | 2010-01-14 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| WO2010017105A1 (en) * | 2008-08-02 | 2010-02-11 | Janssen Pharmaceutica N.V. | Urotensin ii receptor antagonists |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN157280B (https=) | 1983-07-15 | 1986-02-22 | Hoechst India | |
| CA1336090C (en) | 1988-08-31 | 1995-06-27 | Isao Hayakawa | Spiro-substituted cyclic amines of quinolone derivatives |
| DE4030059A1 (de) | 1990-09-22 | 1992-03-26 | Bayer Ag | Verfahren zur herstellung von 5-hydroxy-3,4,5,6-tetrahydro-pyrimidin-derivaten |
| DE4032560A1 (de) | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
| ES2150941T3 (es) | 1992-04-03 | 2000-12-16 | Upjohn Co | Aminas biciclicas-heterociclicas eficaces farmaceuticamente. |
| US5279359A (en) | 1992-06-26 | 1994-01-18 | Erickson Donald C | Rotary trisorption heat pump |
| US5350791A (en) | 1992-07-02 | 1994-09-27 | Henkel Corporation | Hydrophilicizing treatment for metal objects |
| US5527910A (en) | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
| RU2158127C2 (ru) * | 1994-12-23 | 2000-10-27 | Варнер-Ламберт Компани | Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция |
| NZ304519A (en) | 1995-03-02 | 2000-01-28 | Upjohn Co | Pydrimido[4,5-b]indoles |
| SI9620103A (sl) * | 1995-07-06 | 1998-10-31 | Novartis Ag | Pirolopirimidini in postopki za njihovo pripravo |
| WO1998029397A1 (en) | 1996-12-27 | 1998-07-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused pyrimidine compounds and medicinal use thereof |
| SI0964865T1 (en) | 1997-01-08 | 2003-08-31 | Pharmacia & Upjohn Company | Pharmaceutically active tricyclic amines |
| ATE265847T1 (de) | 1997-07-29 | 2004-05-15 | Upjohn Co | Selbstemulgierbare formulierung enthaltend lipophile verbindungen |
| US6147085A (en) | 1999-04-01 | 2000-11-14 | Neurogen Corporation | Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives |
| EP1068207A1 (en) | 1998-04-02 | 2001-01-17 | Neurogen Corporation | AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
| US6221875B1 (en) | 1998-04-02 | 2001-04-24 | Neurogen Corporation | Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands |
| JP2000038350A (ja) | 1998-05-18 | 2000-02-08 | Yoshitomi Pharmaceut Ind Ltd | 糖尿病治療薬 |
| WO2000066585A1 (en) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
| SK10572002A3 (sk) | 2000-01-24 | 2003-10-07 | Warner-Lambert Company | 3-Aminochinazolín-2,4-diónové antibakteriálne činidlá |
| FR2816509B1 (fr) | 2000-11-15 | 2004-02-06 | Sod Conseils Rech Applic | Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene |
| JP2005515173A (ja) | 2001-10-31 | 2005-05-26 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | ピリミド［４，５−ｂ］インドール誘導体 |
| WO2003057149A2 (en) | 2001-12-28 | 2003-07-17 | Bayer Corporation | 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones |
| TWI270549B (en) | 2002-12-26 | 2007-01-11 | Taisho Pharmaceutical Co Ltd | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| WO2004058764A1 (en) * | 2002-12-27 | 2004-07-15 | Bayer Healthcare Ag | 4-phenyl-pyrimido [4,5-b] indole derivatives |
| US20090143399A1 (en) | 2003-10-14 | 2009-06-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
| US20080051414A1 (en) | 2003-10-14 | 2008-02-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
| US20090099165A1 (en) | 2003-10-14 | 2009-04-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
| JP2006036762A (ja) | 2004-06-25 | 2006-02-09 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
| JP2007161585A (ja) | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
| WO2008007113A2 (en) | 2006-07-14 | 2008-01-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| CA2604284A1 (en) | 2005-04-28 | 2006-11-02 | Supergen, Inc. | Protein kinase inhibitors |
| US20070049591A1 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Inhibitors of MAPK/Erk Kinase |
| JP2007169216A (ja) | 2005-12-22 | 2007-07-05 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
| US20080207632A1 (en) | 2006-10-31 | 2008-08-28 | Supergen, Inc. | Protein kinase inhibitors |
| US8618121B2 (en) | 2007-07-02 | 2013-12-31 | Cancer Research Technology Limited | 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors |
| WO2009091476A1 (en) | 2008-01-14 | 2009-07-23 | Irm Llc | Compositions and methods for treating cancers |
| WO2011056739A1 (en) | 2009-11-03 | 2011-05-12 | Glaxosmithkline Llc | Compounds and methods |
| EP2686320B1 (en) * | 2011-03-15 | 2016-05-18 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| CN105189505B (zh) * | 2012-09-12 | 2019-03-22 | 默克夏普&多梅有限公司 | 用作抗菌剂的三环促旋酶抑制剂 |
| CN105899511B (zh) * | 2013-09-11 | 2019-06-07 | 默沙东公司 | 三环促旋酶抑制剂 |
| WO2016067009A1 (en) * | 2014-10-28 | 2016-05-06 | Redx Pharma Plc | Compounds with activity against bacteria and mycobacteria |
-
2012
- 2012-03-14 EP EP12710633.4A patent/EP2686320B1/en active Active
- 2012-03-14 RU RU2013140798A patent/RU2626979C2/ru active
- 2012-03-14 CN CN201280020849.4A patent/CN103562208B/zh active Active
- 2012-03-14 AR ARP120100830A patent/AR085806A1/es active IP Right Grant
- 2012-03-14 US US13/496,188 patent/US9732083B2/en active Active
- 2012-03-14 JP JP2013558143A patent/JP6140083B2/ja active Active
- 2012-03-14 KR KR1020137026970A patent/KR20140059164A/ko not_active Ceased
- 2012-03-14 KR KR1020197025342A patent/KR102132574B1/ko active Active
- 2012-03-14 WO PCT/US2012/029104 patent/WO2012125746A1/en not_active Ceased
- 2012-03-14 BR BR112013023266A patent/BR112013023266B8/pt active IP Right Grant
- 2012-03-14 PH PH1/2013/501800A patent/PH12013501800A1/en unknown
- 2012-03-14 CA CA2829939A patent/CA2829939C/en active Active
- 2012-03-14 MX MX2013010511A patent/MX345780B/es active IP Right Grant
- 2012-03-14 TW TW101108646A patent/TWI527818B/zh active
- 2012-03-14 AU AU2012229997A patent/AU2012229997B2/en active Active
-
2013
- 2013-09-01 IL IL228220A patent/IL228220A/en active IP Right Grant
- 2013-10-11 ZA ZA2013/07583A patent/ZA201307583B/en unknown
-
2017
- 2017-07-07 US US15/643,760 patent/US10858360B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003062443A2 (en) * | 2001-11-08 | 2003-07-31 | Antex Pharma, Inc. | Novel substituted alkane compounds and uses thereof |
| US20050227992A1 (en) * | 2003-10-14 | 2005-10-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein kinase inhibitors |
| CN101282946A (zh) * | 2005-08-05 | 2008-10-08 | 海布里詹尼克斯股份公司 | 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 |
| WO2009029473A1 (en) * | 2007-08-27 | 2009-03-05 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| WO2010006032A1 (en) * | 2008-07-10 | 2010-01-14 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| WO2010017105A1 (en) * | 2008-08-02 | 2010-02-11 | Janssen Pharmaceutica N.V. | Urotensin ii receptor antagonists |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103562208B (zh) | 三环促旋酶抑制剂 | |
| TWI639602B (zh) | 三環旋轉酶抑制劑 | |
| TWI902715B (zh) | 作為ｐａｒｐ７抑制劑的嗒酮 | |
| US11124511B2 (en) | Heterocyclic compounds as immunomodulators | |
| WO2021088945A1 (zh) | 作为shp2抑制剂的化合物及其应用 | |
| TWI823420B (zh) | 用作cdk激酶抑制劑的化合物及其應用 | |
| CN108349947A (zh) | 四氢吲唑及其医药用途 | |
| CN115667218A (zh) | 激酶抑制剂 | |
| TWI918605B (zh) | 作為治療劑之細胞毒素之肽結合物 | |
| HK40112157A (zh) | Enpp1抑制剂的药物用途 | |
| NZ614983B2 (en) | Tricyclic gyrase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Massachusetts, USA Applicant after: TRIUS THERAPEUTICS Inc. Applicant after: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC Address before: California, USA Applicant before: TRIUS THERAPEUTICS INC. Applicant before: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC |
|
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Massachusetts, USA Applicant after: TRIUS THERAPEUTICS Inc. Applicant after: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC Address before: California, USA Applicant before: TRIUS THERAPEUTICS INC. Applicant before: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160310 Address after: New jersey, USA Applicant after: MERCK SHARP & DOHME Corp. Applicant after: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC Address before: Massachusetts, USA Applicant before: TRIUS THERAPEUTICS INC. Applicant before: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20221114 Address after: new jersey Patentee after: MERCK SHARP & DOHME B.V. Patentee after: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC Address before: new jersey Patentee before: MERCK SHARP & DOHME Corp. Patentee before: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC |
|
| TR01 | Transfer of patent right |